He aims for innovative technology in medicine

Joakim Lundeberg, professor of molecular biotechnology at KTH Royal Institute of Technology, has received just over 30 million kronor from the Swedish Research Council's distinguished professor grant for research primarily into medical issues. How does it feel?
"A tremendous joy and pride in receiving this prestigious grant."
"The grant, which runs for eight years, gives me unique opportunities to create a stable and long-term research environment that I believe will provide even better conditions for conducting good innovative research."
What is the research about?
"We will work on developing new and improved methods to study and localise biomolecules in tissue sections. We have successfully studied the activity of genes in different tissues in the past, and are now continuing to map metabolites and peptides, among others. A medically important cell type that is currently prioritised in our research is immune cells."
"We want to use our methods to create a new picture of different tissue ecosystems in health and disease. In addition to new experimental techniques, we will utilise our multidimensional database to generate new methods for AI prediction."
How can it be useful and applied?
"Our goal is to develop innovative technologies that can be used in particular in medical issues such as organ development, neurological diseases and cancer.”
"Furthermore, we believe that our research will lead to new insights and improved methods in clinical practice with patient benefit, and also inspire new business ideas."
Text: Christer Gummeson